ONO PHARMACEUTICAL CO
🇯🇵Japan
Controlled Study of ONO-8025 (KRP-197) in Patients With Overactive Bladder in Japan
Phase 2
Completed
- Conditions
- Overactive Bladder
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2012-10-12
- Lead Sponsor
- Ono Pharmaceutical Co. Ltd
- Target Recruit Count
- 400
- Registration Number
- NCT00212706
Controlled Study of ONO-5920 in Patients With Involutional Osteoporosis in Japan
Phase 3
Completed
- Conditions
- Involutional Osteoporosis
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2012-10-11
- Lead Sponsor
- Ono Pharmaceutical Co. Ltd
- Target Recruit Count
- 650
- Registration Number
- NCT00212667
Controlled Study of ONO-5920 in Patients With Involutional Osteoporosis in Japan
Phase 3
Completed
- Conditions
- Involutional Osteoporosis
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2012-10-11
- Lead Sponsor
- Ono Pharmaceutical Co. Ltd
- Target Recruit Count
- 250
- Registration Number
- NCT00212719
Controlled Study of ONO-2506PO in Patients With Parkinson's Disease in Japan
Phase 2
Completed
- Conditions
- Parkinson's Disease
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2012-10-11
- Lead Sponsor
- Ono Pharmaceutical Co. Ltd
- Target Recruit Count
- 165
- Registration Number
- NCT00212693
Controlled Study of ONO-8025 (KRP-197) in Patients With Overactive Bladder in Japan
Phase 3
Completed
- Conditions
- Overactive Bladder
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2012-10-11
- Lead Sponsor
- Ono Pharmaceutical Co. Ltd
- Target Recruit Count
- 750
- Registration Number
- NCT00212732
Controlled Study of ONO-1101 in Patients With Postoperative Tachyarrhythmias in Japan
Phase 2
Completed
- Conditions
- Postoperative Supraventricular Tachyarrythmia
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2012-10-11
- Lead Sponsor
- Ono Pharmaceutical Co. Ltd
- Target Recruit Count
- 165
- Registration Number
- NCT00212654
ONO-7436 Phase II Study in Japan
Phase 2
Completed
- Conditions
- Malignant Tumor
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2012-06-14
- Lead Sponsor
- Ono Pharmaceutical Co. Ltd
- Target Recruit Count
- 420
- Registration Number
- NCT00212602
- Locations
- 🇯🇵
Chubu Region Facility, Chubu, Japan
🇯🇵Chugoku Region Facility, Chugoku, Japan
🇯🇵Hokkaido Region Facility, Hokkaido, Japan
Controlled Study of ONO-5920 in Patients With Involutional Osteoporosis in Japan
Phase 3
Completed
- Conditions
- Involutional Osteoporosis
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2012-06-14
- Lead Sponsor
- Ono Pharmaceutical Co. Ltd
- Target Recruit Count
- 444
- Registration Number
- NCT00212628
- Locations
- 🇯🇵
Chubu Region Facility, Chubu, Japan
🇯🇵Chugoku Region Facility, Chugoku, Japan
🇯🇵Hokkaido Region Facility, Hokkaido, Japan